Immunological Aspects of Clinical Leprosy
Mycobacterium lepree is a relatively innocuous organism which possesses a long replication time in vivo, and which so far has not been cultured in vitro. The various disease states associated with M. lepra infection do not seem to be associated with the production of any 'toxin' by the organism, but are probably due to the various ways in which the body responds to infection with the organism. Protection against M. lepra, like that against M. tuberculosis, appearsto depend on cell-mediated rather than humoral (immunoglobulin) mechanisms. Nevertheless the bacillus is as capable of stimulating a humoral antibody response as any other organism. The clinical manifestations of leprosy can be attributed either to a specific deficiency in cell-mediated immunity or to an over-reaction of this response. However, under certain circumstances lesions can be produced by the interaction of soluble mycobacterial antigen and humoral antibody.
The Spectrum of Clinical Leprosy (Table 1) Leprosy can present clinically in a wide variety of forms. Original attempts at classification separated those forms of the disease where the presentation was one mainly of peripheral nerve damage from the type where the lesions took the form mainly of nodular deposits in the skin. The association of anesthetic patches in the skin with a surrounding raised erythematous edge or with a large erythematous plaque led to the description of these lesions as 'tuberculoid'. The nodular lesions are generally referred to as lepromatous as they are typical of this form of the disease. Thus leprosy was divided into two polar forms, 'tuber-culoid' and 'lepromatous'. However, more recently many descriptions have been made of patients who may show at one and the same time manifestations of both forms of the disease. This form of leprosy has been referred to as 'dimorphous' or 'borderline' leprosy. Occasionally patients may present with one or more hypopigmented macules. These patients may be difficult to classify into one of the more florid forms of the disease, and are regarded as indeterminate leprosy. However, these patients rarely stay in this state and the disease may develop with the production of more typical tuberculoid or lepromatous lesions. It is thought that the 'indeterminate' state is probably the earliest form of the disease through which many patients pass before they develop typical manifestations of tuberculoid or lepromatous leprosy.
Clinically, therefore, leprosy forms a spectrum between the two polar forms 'tuberculoid' and 'lepromatous' leprosy in which patients may present with varying lesions depending to what degree the'tuberculoid' or 'lepromatous'elements contribute to the disease.
Histological examination of the lesions of leprosy show that the lesions of tuberculoid leprosy are infiltrated with a dense collection of small lymphocytes and, despite well-defined collections of histiocytic cells, M. leprw is rarely found. This is in marked contrast to the appearance in lepromatous leprosy where small lymphocytes are absent or scanty and the macrophages are packed with 'globi' of leprosy bacilli. It would therefore appear that the condition, lepromatous leprosy, develops as a consequence of a defect in the function of cell-mediated immunity which allows the organisms to proliferate intracellularly in macrophages in an uncontrolled manner. In tuberculoid leprosy at the other extreme there is a heightened degree of cell-mediated immunity; not only arethe organisms eliminated but lesions are produced as a result of a delayed hypersensitivity reaction directed against, presumably, residual mycobacterial antigens. The disease is, however, not always static and the patient is often considered to be in a 'mobile' state. A patient near the tuberculoid end of the spectrummaymoveto a more borderline position, or a patient who has the borderline form of the disease may move to the lepromatous end of the spectrum as a result of a gradual loss of cellmediated immunity. Conversely, on sulphone therapy, as the bacterial load is reduced, the patient may regain his cell-mediated immunity and may move from the lepromatous end of the scale towards a more borderline position, or a patient with borderline leprosy may move towards a tuberculoid position in the spectrum.
The Basisfor the Loss of Cellular Immunity in Lepromatous Leprosy
The fundamental lesion in lepromatous leprosy appears to be a specific state of immunological tolerance affecting cell-mediated immunity but not antibody production which is, if anything, enhanced.
However, the specificity of the immunological unresponsiveness in lepromatous leprosy is by no means clear. Patients with this condition do not develop a positive lepromin test. A proportion are tuberculin positive, although the skin reactivity to this antigen is on the whole depressed as is the skin reactivity to extracts of Candida albicans (Bullock 1968 ). The observations that a high proportion of these patients cannot be sensitized to 2, 4-dinitrochlorobenzene (Waldorf et al. 1966) and may show delayed rejection of skin homografts (Hart & Rees 1967) , associated with the finding that their in vitro lymphocyte response to phytohrTmagglutinin was impaired , suggested that the basis of the failure of cellular immunity in leprosy was nonspecific and could be accounted for through a constitutional lowering of the ability of such patients to develop cell-mediated immune responses. A number of other observations were also in keeping with this concept. There is no doubt that a fundamental constitutional defect must contribute to the eventual deficiency. This is indicated by the observation that lepromatous disease is a host-determined characteristic that is possessed by a fixed proportion of all people everywhere. In a population where the rate of leprosy infection is decreasing, there is not a parallel drop in the incidence of the lepromatous form of the disease (Newell 1966) . Moreover, there have been reports of a naturally occurring weakness in the ability to develop cell-mediated immune responses in the families of patients with leprosy when compared with families from the same background in which there was no history of leprosy (Jamison & Vollum 1968) . A disease resembling lepromatous leprosy can be produced in mice in which cellmediated immunity has been suppressed by neonatal thymectomy and irradiation with 900 R , and this can be reversed by transplanting lymphoid tissue from mice with a normal state of cell-mediated immunity.
However, there are a number of factors which indicate that nonspecific failure of cell-mediated immunity cannot account completely for the massive proliferation of organisms throughout the tissues in the human lepromatous disease. If cell-mediated immunity were suppressed nonspecifically to the degree necessary for this to occur, there should be signs of chronic infections with other organisms. However, patients with leprosy are not unduly prone to secondary infection, apart from those resulting directly from factors associated with their disease (e.g. ulceration and infection of anesthetic limbs). If they receive prolonged effective antileprosy treatment they have a normal life expectancy. The prognosis of patients with lepromatous leprosy may be contrasted with that of babies with complete deficiency of cellmediated immunity as a result of thymic agenesis (Di George or Nezelof syndrome) who die in early infancy from multiple intercurrent infections. It therefore appears that any nonspecific failure of cell-mediated immunity is partial and cannot account for the massive infiltration of the tissues with M. lepra found in lepromatous leprosy. In an attempt to investigate the ability of such patients to develop a cell-mediated immune response, Dr Waters and I sensitized 17 lepromatous patients simultaneously with 2,4-dinitrochlorobenzene (DNCB) and with keyhole limpet hemocyanin. Nine of these failed to become sensitized to DNCB, as might have been expected from previous reports. However, all 9 could be induced to show a delayed hypersensitivity to the hemocyanin. It thus appears that the nonspecific failure of cell-mediated immunity in lepromatous leprosy is not absolute, but is a relative phenomenon. By the use of a stronger antigen (hoemocyanin), it was possible to induce a cell-mediated immune response in patients who would not respond to the relatively weaker antigenic stimulus (DNCB) (Turk & Waters 1969) . A similar nonspecific depression of cell-mediated immunity can be found in Hodgkin's disease and this had been shown to be related to the extent of the replacement of the lymphoid tissue by pathological tissue (Brown et al. 1967) . In lepromatous leprosy there is replacement of certain parts of the peripheral lymphoid tissue by a massive infiltration with histiocytes which often contain large numbers of bacilli (Turk & Waters 1968 ). The areas replaced by the pathological tissues are those through which the mobile pool of small lymphocytes involved in cell-mediated immune reactions are continuously passing. These are the paracortical areas of the lymph node where these lymphocytes proliferate during the development of a cell-mediated immunological response (Oort & Turk 1965) , and are dependent on thymus integrity in neonatal life (Parrott et al. 1966 ). The appearance of these lymph nodes is very similar to those seen in experimental animals treated with antilymphocyte serum (Turk & Willoughby 1967) . The paracortical areas are depleted of small lymphocytes, whereas the germinal centres, their marginal cuff of small lymphocytes, and the plasma cells at the corticomedullary junction and in the medullary cords, involved in antibody synthesis, are unaffected. It is probable that this replacement of the paracortical area or diffuse cortex of the lymphoid tissue is due to infiltration with histiocytes which have travelled down the afferent lymphatics from the peripheral lesions and displaced the small lymphocytes which normally pass through this area (Gaafar & Turk 1970) . To what extent this mechanical replacement of the areas of lymphoid tissue, wherelymphocytes proliferate, is responsible for the nonspecific failure of cell-mediated immunity is not known. However, the humoral antibody-producing mechanism is normal and plasma cells in the lymphoid tissue markedly increased in number which could account for the high titres of precipitating antibodies against mycobacterial antigens (Rees et al. 1965 ) and the high incidence of different autoantibodies in the serum of these patients (Bonomo & Dammacco 1968). Another factor may also be involved and this is a reduced ability of lymphocytes from these patients to respond to phytohoemagglutinin . Such a failure of lymphocyte functionappearsto be a general correlate of reduced states of cell-mediated immunity in Hodgkin's disease and in conditions of thymus dysfunction. The observation by Bullock & Fasal (1968) of a serum factor in leprosy patients which inhibits transformation of normal lymphocytes by streptolysin 0, has been enlarged by Nelson & Waters (personal communication) who have found a similar factor which suppresses lymphocyte transformation by PHA. Thus it may be that the relative suppression of cell-mediated immunity in lepromatous leprosy could be due to the presence of an increased level of circulating antilymphocyte factors. One possible explanation, which could be considered, is that among the large number of autoantibodies circulating in this condition there may be antilymphocytic antibodies. Another nonspecific factor that could be relevant to the depression of cell-mediated immunity in leprosy is that this can be suppressed in experimental animals by injection of dead mycobacteria in oil (Jankovic 1962) . To summarize, it is possible that M. lepra? first begins to infiltrate the tissues as a result of a constitutional reduction in the ability ofthe individual to cope with this organism. As the organism proliferates so much antigen accumulates in the body that a state of 'high zone' immunological tolerance develops, affecting cell-mediated immune processes only. With futher infiltration of the tissue and the production of certain circulatory antilymphocytic factors a degree of nonspecificity enters the loss of cell-mediated immunity so that patients cannot be sensitized to DNCB and retain skin homografts longer than normal. However, this is never so great that they cannot develop delayed sensitivity to haemocyanin, or have an increased susceptibility to intercurrent infection or increased incidence of cancer. In certain patients following treatment with sulphones, as the antigenic load is reduced, cellmediated immunity recovers and the patient will move clinically across the spectrum from lepromatous to borderline leprosy or from borderline leprosy to tuberculoid leprosy. Under these conditions the lesions may flare up due to the reaction between the returning lymphocytes and mycobac-terial antigen and the patient may then develop what is known as a 'reversal reaction'.
Erythema Nodosum Leprosum (ENL)
In reversal reactions in leprosy the main infiltrating cell is the lymphocyte and the lesion resembles a tuberculin reaction. However, another type of reaction can occur in the skin of patients with lepromatous leprosy. This condition, called erythema nodosum leprosum, develops in lepromatous patients on chemotherapy at a time when massive destruction of the organisms is occurring. The lesions are generally erythematous and indurated, but may become necrotic, pustular or hemorrhagic. Histologically the lesions are characterized by an intense perivascular infiltrationwith polymorph leukocytes. The vessels in the centre of the lesions may show fibrinoid necrosis and swelling of their endothelium. The tissues round the damaged vessels are cedematous. The appearance both clinically and histologically is that of an Arthus reaction. Moreover, the patients may have other evidence of immune complex deposition. This includes fever, albuminuria, arthritis and iridocyclitis.
Using the indirect fluorescent antibody technique, it was possible to demonstrate granular deposits of immunoglobulin and complement in a perivascular deposition in the dermis in lOout of 17 patients examined (Wemambu et al. 1969) . The distribution of these deposits corresponded to the areas of polymorph infiltration. In a few of the patients examined evidence was also found that there was soluble mycobacterial antigen present in the lesion. The failure to find deposits in 7 patients examined is consistent with the observation in experimental animals that no such deposits can be found in Arthus reactions examined 24 hours after their induction. A further observation of interest is that extremely high serum levels ofthe third component of complement (over 2-5 mg/ml) were found in some of the patients with ENL. High levels of the second component have also been described in this condition (Saitz et al. 1968 ). ENL is therefore due to a hypersensitivity reaction against free mycobacterial antigen, produced by the deposition of immune complexes containing antibody and complement in the tissues. This occurs under conditions where specific cell-mediated immune processes have been suppressed but humoral antibody is present in high concentration in the circulation. The prototype of infections caused by leishmania is simple cutaneous leishmaniasis (oriental sore) which is a self-healing disease. Some weeks after inoculation of Leishmania tropica by a sandfly of the genus Phlebotomus a nodule appears in the skin (Rahim & Tartar 1967) . After a period varying from 2 to 8 months this ulcerates and is covered by a crust. The lesion may then remain almost unchanged for up to a further 12 months, when it starts to heal slowly, leaving in the end a characteristic depressed mottled scar.
For some years it has been realized that cutaneous leishmaniasis presents a spectrum of disease similar to that seen in leprosy (Destombes 1960). The extreme ends of the spectrum are not as common as in leprosy and are seen only in certain geographical areas, which might suggest that differences in host genetics, parasite strains or epidemiological events influencing host-parasite contact may affect clinical patterns of disease. But there is evidence that many of the clinical features ofthe disease in an individual patient reflect, or are determined by, his cell-mediated immune response to the parasite.
At one end of the spectrum lies lupoid or recidiva leishmaniasis. The story is of a simple oriental sore that never quite healed or healed and relapsed (Dostrowsky 1936) ; classically there is a typical
